ABOUT CNY PSYCHIATRY
Thoughtful Psychiatric Care. Evidence-Based Treatment. Responsible Innovation.
CNY Psychiatry was founded in 2019 with an initial focus on expanding access to Transcranial Magnetic Stimulation for patients with difficult-to-treat depression.
But the practice grew from a broader concern about psychiatric care: when patients do not improve, it is too easy for treatment to become an endless sequence of prescriptions and procedures without sufficiently reconsidering the diagnosis, the treatment strategy, or what recovery should actually look like.
CNY Psychiatry was built around a different premise. Before asking which treatment to provide, we should first understand the person we are trying to help.
OUR STORY
The practice began with TMS, but TMS was never intended to become the identity of the practice.
As our work with treatment-resistant illness grew, so did the range of treatments we could responsibly offer. CNY Psychiatry developed programs in IV ketamine, Spravato® and accelerated TMS while continuing to provide psychiatric consultation and ongoing psychiatric treatment.
The result is a practice that can consider multiple treatment options without needing every patient to fit a single treatment model.
Our identity is not “the TMS clinic” or “the ketamine clinic.”
CNY Psychiatry is a psychiatric practice focused on thoughtful evaluation and evidence-based treatment of complex psychiatric illness.
UNDERSTANDING BEFORE TREATING
Psychiatric symptoms do not exist in isolation.
Depression can be influenced by trauma, anxiety, obsessive symptoms, sleep, medical illness, substance use, relationships, behavior, purpose, and the broader circumstances of a person’s life.
A diagnosis is important, but it is not the whole person.
We believe good psychiatric evaluation requires careful listening, comprehensive assessment, and a willingness to reconsider assumptions when previous treatment has not worked.
EVIDENCE-BASED REASONING
Psychiatry continues to evolve.
Some treatments have decades of evidence behind them. Others are newer and supported by a developing literature. Some are FDA-approved for a particular condition; others are used off-label when the available evidence and clinical circumstances justify consideration.
We believe patients deserve to understand those distinctions. Innovation should never mean adopting something simply because it is new. It means following the evidence closely enough to recognize when an emerging treatment may offer a meaningful advantage, and being equally willing to acknowledge uncertainty when the evidence remains incomplete.
THE RIGHT TREATMENT FOR THE RIGHT PATIENT AT THE RIGHT TIME
TMS can be transformative for one patient and the wrong treatment for another.
The same is true of ketamine, Spravato, medication, psychotherapy, and other psychiatric treatments.
Our goal is not to move patients through a predetermined sequence of procedures.
It is to understand the diagnosis, previous treatment, symptoms, function, medical circumstances, preferences, and goals well enough to recommend what makes sense for that individual.
COLLABORATIVE CARE
Many patients who come to CNY Psychiatry already have psychiatrists, psychiatric nurse practitioners, therapists, or primary care clinicians.
We value those relationships.
Specialty consultation or interventional treatment does not require a patient to abandon an established treatment team. With appropriate consent, we welcome collaboration and communication with the clinicians who already know the patient.
OUR PHILOSOPHY
Psychiatric expertise is not simply prescribing medication or performing procedures.
Medication is a tool. TMS is a tool. Ketamine is a tool. Spravato is a tool.
Clinical judgment is the service.
We believe hope is built on understanding, strengthened by evidence, and sustained through partnership.